Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
REPL · against 417 other Healthcare companies of similar size
Ranked #280 of 418 · scores higher than 33% of peers · safety percentile 37
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)37 peers with a safety percentile of 30–39, including REPL · Click a bar to see the companies
A mix: stronger current ratio, but weaker debt / equity and beta than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | REPL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 396 reported | 1.06× | 0.22× | 14% | 33% | |
| BetaLower is better · 393 reported | 0.94 | 0.54 | 29% | 33% | |
| Current ratioHigher is better · 402 reported | 5.23× | 2.88× | 73% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 1.2B USD | 100 | 40 | |
| 3 | 2.6B USD | 100 | 43 | |
| 4 | 1.1B USD | 100 | ||
| 5 | 3.6B USD | 99 | ||
| 276 | 7.1B CNY (≈$998M) | 38 | 56 | |
| 277 | 19.0B CNY (≈$2.7B) | 38 | 55 | |
| 278 | 1.6B USD | 37 | 33 | |
| 279 | 145.4B JPY (≈$989M) | 37 | 36 | |
| 280 | 1.9B USD | 37 | 18 | |
| 281 | 2.5B USD | 37 | 31 | |
| 282 | 1.2B USD | 37 | ||
| 283 | 22.1B CNY (≈$3.1B) | 36 | 49 | |
| 284 | 10.4B CNY (≈$1.5B) | 36 | 42 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score